Approval · Notice of Compliance 4376 · 1996
PULMOZYME: Notice of Compliance 4376
Issued June 13, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4376
- Date
- June 13, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- An enzyme that cleaves dna
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PULMOZYME | 02046733 | Marketed |
Medicinal ingredients
- DORNASE ALFA 1 MG per ML